Rawstron A, Laycock-Brown G, Hale G, Davies F, Morgan G, Child J, Hillmen P, Owen R. CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy. Haematologica 2006; 91(11):1577-1578.